Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 2
Submit an article Journal homepage
185
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

High levels of CD160 expression up-regulated counts of chronic lymphocytic leukemia cells and were associated with other clinical parameters in Chinese patients with chronic lymphocytic leukemia

Zheng-Hao ZhangDepartment of Hematology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
,
Shu ChenDepartment of Pathology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
,
Shuang ChenDepartment of Hematology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
,
Yang LiuDepartment of Hematology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
&
Jian-Hua QuDepartment of Hematology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, ChinaCorrespondence[email protected]
Pages 529-532 | Received 15 Oct 2013, Accepted 12 May 2014, Published online: 17 Jul 2014

References

  • Hallek M. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. Am J Hematol 2013;88:803–816.
  • Xu W, Cao X, Miao KR, et al. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Hematol 2009;90:205–211.
  • Xu W, Li JY, Pan JL, et al. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. Int J Hematol 2007;85:430–436.
  • Kowal M. Recent progress in prognostic markers and treatment of chronic lymphocytic leukemia. Pol Arch Med Wewn 2006;116:888–895.
  • Furman RR. Prognostic markers and stratification of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2010:77–81.
  • Chiorazzi N. Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2012:76–87.
  • Giustiniani J, Bensussan A, Marie-Cardine A. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 2009;182:63–71.
  • Le Bouteiller P, Tabiasco J, Polgar B, et al. CD160: a unique activating NK cell receptor. Immunol Lett 2011;138:93–96.
  • Farren TW, Giustiniani J, Liu FT, et al. Differential and tumor-specific expression of CD160 in B-cell malignancies. Blood 2011;118: 2174–2183.
  • Liu FT, Giustiniani J, Farren T, et al. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. Blood 2010;115:3079–3088.
  • Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
  • Le Garff-Tavernier M, Herbi L, de Romeuf C, et al. Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion. Leukemia 2014;28:230–233.
  • Fang C, Zhuang Y, Wang L, et al. High levels of CD20 expression predict good prognosis in chronic lymphocytic leukemia. Cancer Sci 2013;104:996–1001.
  • Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res 2009;33:1212–1216.
  • Pillai V, Pozdnyakova O, Charest K, et al. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders. Am J Clin Pathol 2013;140:536–543.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.